CD4 and liver cancer: While no loss-of-function mutations of PPARA have been reported, results from these studies suggest that mutant, less functional PPARα could be a risk factor for liver cancer due to dysfunctional regulation of linoleic acid metabolism, reduced CD4+ T cell presence and function, and increased hepatocyte senescence.